Vitaros® offers rapid onset with significant efficacy, tolerability and a favorable safety profile, including patients with compromised cardiovascular system such as diabetics or patients not responding to Viagra after a prostatectomy. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More